Gartner® Report

"LIFE SCIENCE TOP ACTIONS FOR 2021: PRIORITIZE COMPOSABILITY IN DIGITAL TRIAL OPERATIONS"

In their latest report, Life Science Top Actions for 2021: Prioritize Composability in Digital Trial Operations, Gartner enjoins Life Science CIOs to begin crucial digital transformation initiatives, and provides technology insights, recommendations, and direction for meeting pressing clinical development needs in 2021.

Access this report to learn Gartner key recommendations, including:

• “Evolve from proprietary vendor solution architectures into new approaches that utilize a composable framework, ensuring business capabilities possess increased business flexibility and can adapt to changing business needs.”
• “Empower clinical development teams to participate directly in the development of applications by modelling applications as compositions of separately packaged business capabilities, rather than discrete silos of data and functionality.”
• “Look beyond the traditional solution categories into clinical trial solutions enhanced by data fabric architecture that enable broader ecosystem and cross-departmental capabilities.”

We believe this Gartner report will provide you with strategic planning assumptions and what you need to know for accelerating your digital transformation journey to adapt to a changing landscape in clinical trial delivery.

According to Gartner, COVID-19’s clinical trial operations disruptions have demonstrated the need for foundational business capabilities that enable agility and flexibility. Life Science CIOs must empower business teams with composable platforms to turbocharge digital innovations and meet new business conditions.”